Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity. 2011

C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
Fluoroorganic Division, Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500607, India.

A series of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives 5 and 6 was prepared starting from 2,3-active functional pyridine 1via cyclization, propargylation followed by reaction with alkyl or perfluoroalkyl azides under Sharpless conditions. All the compounds 5 and 6 were screened for anticancer activity against three cancer cell lines such as U(937), THP-1 and Colo205. The promising compounds 5b and 5e have been identified.

UI MeSH Term Description Entries
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide

Related Publications

C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
July 1989, Die Pharmazie,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
May 2018, Bioorganic & medicinal chemistry letters,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
January 2015, Chemical & pharmaceutical bulletin,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
May 2013, European journal of medicinal chemistry,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
November 1995, Die Pharmazie,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
December 2023, Journal of enzyme inhibition and medicinal chemistry,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
December 2012, European journal of medicinal chemistry,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
September 2019, Future medicinal chemistry,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
June 2016, Bioorganic & medicinal chemistry letters,
C Kurumurthy, and P Sambasiva Rao, and B Veera Swamy, and G Santhosh Kumar, and P Shanthan Rao, and B Narsaiah, and L R Velatooru, and R Pamanji, and J Venkateswara Rao
January 2001, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!